Skip to main content

Table 2 EGD indication, procedure, and results

From: Prediction of esophagogastroduodenoscopy therapeutic usefulness for in-ICU suspected upper gastrointestinal bleeding: the SUGIBI score study

 

EGD (n = 255)

Time from admission (days, mean ± SD)

8.3 ± 13

EGD indication, n (%)*

 

 Anemia

203 (79.6)

 Melena

49 (19.2)

 Hemodynamic instability

37 (14.5)

 Hematemesis/blood in NGT

35 (13.7)

 Hematochezia

35 (13.7)

Intubation solely for EGD, n (%)

61 (23.9)

EGD results, n (%)

 

 Normal

62 (24.3)

 Ulcer

59 (23.1)

 EV

20 (7.8)

 Esophagitis

48 (18.8)

 Mallory–Weiss

5 (2)

 Gastritis

32 (12.5)

 NGT-induced lesion

7 (2.7)

 Other

12 (4.7)

 Multiple lesions

41 (16.1)

 Lesion considered responsible for GI bleeding

110 (43.1)

Hemostatic procedure, n (%)**

33 (12.9)

 Hemostatic clip

19 (58)

 Epinephrine instillation

16 (48)

 EV ligature

14 (42)

 Other (Hemospray™/Gold probe™/APC)

5 (15)

  1. EGD esophagogastroduodenoscopy, NGT nasogastric tube, EV esophageal varices, EBO endobrachyesophagus, GI gastrointestinal, APC Argon plasma coagulation. *Some patients had EGD for multiple indications. **Some patients received multiple means of hemostasis during EGD